Nutex Health Announces Extension of Share Repurchase Program Until 2026

Nutex Health Extends Share Repurchase Plan

On December 4, 2025, Nutex Health Inc. (NASDAQ: NUTX), a healthcare delivery system based in Houston, announced an extension of its previously authorized stock repurchase program. This decision reflects the Board of Directors' confidence in the company's long-term strategy and commitment to enhancing shareholder value.

Originally initiated on August 14, 2025, the program allowed for the buyback of up to $25 million worth of common stock over a six-month period, starting after the filing of the Q2 2025 Form 10-Q. With this extension, the timeline has now been moved to March 31, 2026. Each repurchase will adhere to the guidelines set by Rule 10b-18 of the Securities Exchange Act of 1934 and will be carried out under a Rule 10b5-1 trading plan initiated on December 4, 2025.

The intention behind this share repurchase initiative is twofold: to boost shareholder value and to counteract any dilution resulting from additional shares issued to fulfill stock compensation requirements for hospitals that are currently under construction or those that are scaling operations.

Repurchase decisions regarding the timing and number of shares will remain at the company's discretion, influenced by various factors such as overall market conditions, the current stock price, financial performance, capital needs, and legal obligations. It is important to note that while there is an authorization in place for the repurchase, it does not compel Nutex Health to purchase any shares and can be modified or halted at any moment.

Nutex Health operates 25 advanced micro-hospitals and outpatient departments across 11 states, focusing on providing integrated healthcare services led by physicians. The company was established in 2011 and has positioned itself as a crucial player in the healthcare market by combining its Hospital Division with a strong Population Health Management Division. The latter oversees provider networks, including Independent Physician Associations, enhancing its service to affiliated hospitals and physician groups through comprehensive management and administrative support.

This decision to extend the stock repurchase program comes at a crucial time as the healthcare sector experiences shifts due to changing regulations, economic fluctuations, and increasing competition. Nutex is mindful of these challenges and aims to ensure its strategic initiatives align with fostering growth and sustainability.

As part of its proactive approach, Nutex Health continues to navigate potential risks associated with its growth strategy, which includes compliance with evolving healthcare regulations and the successful execution of its operational goals. Stakeholders remain optimistic about the company’s ability to drive value, especially with the ongoing developments in the healthcare landscape.

In conclusion, the extension of the share repurchase program signifies Nutex Health’s dedication to shareholders, demonstrating their strategic foresight and a robust plan to mitigate share dilution while pursuing long-term growth objectives. With a comprehensive approach to healthcare delivery and a commitment to innovative solutions, Nutex Health is poised to enhance its position within the industry over the coming years.